Jun. 12 at 7:10 PM
$HSPT SL Science Holding (Nasdaq: SLBT) closed its business combination with Horizon Space Acquisition II, with both now wholly owned subsidiaries of SL Science. Ordinary shares are expected to begin trading on the Nasdaq Global Market under ticker SLBT on June 15, 2026.
The deal implies an equity valuation for SL Bio of about
$5.568 billion and includes a concurrent
$7.8 million PIPE, supporting development of Gamma delta T cell “off-the-shelf” therapies for solid tumors and funding global expansion with an expanded executive team and independent board.